Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dana-Farber’s Belfer Institute for Applied Cancer Science to Present and Lead Sessions at the American Association for Cancer Research Annual Meeting 2012

Published: Tuesday, March 27, 2012
Last Updated: Tuesday, March 27, 2012
Bookmark and Share
The Belfer Institute of Applied Cancer Science is a fully integrated, collaborative cancer research center offering innovative drug discovery capabilities.

The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute today announced that the Institute will present data, participate in panel discussions and lead educational sessions at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2012, being held at McCormick Place in Chicago from Saturday, March 31 to Wednesday, April 4. The Belfer Institute of Applied Cancer Science is a fully integrated, collaborative cancer research center offering innovative drug discovery capabilities that range from the identification of cancer-causing genetic mutations to the full validation and selection of new drug targets. Working collaboratively together, across scientific disciplines, and closely with corporate partners, this team of distinguished faculty is driving the discovery of new cancer targets, defining the biological context of those targets and working to co-develop the next generation of novel cancer therapies.

“The Belfer Institute is honored to be presenting and speaking with top oncology researchers at the annual AACR meeting,” said Pasi Janne, M.D., Ph.D., scientific director of the Belfer Institute for Applied Cancer Science. “There has been significant recent progress made in the growth and evolution of the Institute, as evidenced by the recent appointment of Jessie English, our new head of research, and in advancing our collaborations with our strategic partners Merck and Sanofi-Aventis. The Belfer Institute is built upon a tradition of research excellence and we look forward to translating this research into a revolutionary next generation of cancer therapies.”

The Belfer Institute for Applied Cancer Science schedule at AACR is as follows:

-- On Saturday, March 31 at 8 a.m., Dr. Janne will chair the educational session, “Established and Emerging Targets in Lung Cancer.” The session will be held 8-10 a.m. in Room S105 at McCormick Place South.

-- On Monday, April 2 at 8:30 a.m., Jessie M. English, Ph.D., head of research of the Belfer Institute for Applied Cancer Science, will co-chair the professional advancement session, “WICR Career Mentoring Session.” The session will be held 8:30-10:30 a.m. in Continental Ballroom B-C at Hilton Chicago Hotel.

-- On Monday, April 2 at 4:55 p.m., Dr. Janne will be a discussant on the special symposium, “Clinical Trials Symposium 3: Clinical Trials of Novel Agents,” following the abstract presentations. The special symposium will be held 3-5:10 p.m. in Room W183 B/C at McCormick Place West.

-- On Tuesday, April 3 at 1:50 p.m., Dr. Janne will give a presentation titled “Therapeutic strategies with mutant selective EGFR kinase inhibitors.” The presentation will be held as part of the session, “Targeting the EGFR Family with Small Molecules,” being held 1-3 p.m. in Room W181 at McCormick Place West.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Novel MRI Technique Distinguishes Healthy Prostate Tissue from Cancer
The UTSW researchers have determined that glucose stimulates release of the zinc ions from inside epithelial cells, which they could then track on MRIs.
Precision Nanobots Target Cancerous Tumours
Researchers achieve breakthrough toward redefining anti-cancer drug administration using nanorobotics.
PARP Proteins Explore Therapeutic Targets in Cancer
Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
Immune-Cell Population Predicts Immunotherapy Response in Melanoma
All patients with high levels of one immune-cell type responded to treatment.
Effects of Chemotherapy on Developing Ovaries in Female Fetuses
Researchers at University of Edinburgh have shown that etoposide can damage the development of the ovaries while a fetus is in the womb.
Breast Tumors Evolve in Response to Hormone Therapy
Researchers have suggested that analyzing a single sample of the breast tumor is insufficient for understanding how a patient should best be treated.
Cutting off the Cancer Fuel Supply
Research from investigators at Rutgers Cancer Institute of New Jersey and Princeton University has identified a new approach to cancer therapy in cutting off a cancer cell’s ‘fuel supply’ by targeting a cellular survival mechanism known as autophagy. The co-corresponding authors of the work are Rutgers Cancer Institute Deputy Director Eileen P. White, PhD, and researcher ‘Jessie’ Yanxiang Guo, PhD.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
New Tech Joins the Battle Against Hep B
A method for “silencing” RNA that emerged from a University of Wisconsin—Madison spinoff company is in clinical trials in Europe, Asia and the United States against hepatitis B, an infection that can destroy the liver.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!